StonvexLoading…
StonvexStonvexStonvexReal-time TradingView chart with full indicator set.
Last 7 days, powered by Finnhub. Tap Analyze to classify direction.
Loading latest news…
Pick the depth your tier unlocks. Logged-in Pro/Premium users automatically get the deeper report.
Free preview · 3 reports / hour · No sign-up required
Factor grades, AI Copilot, personalized ranking, and deeper event analysis.
Upgrade to Pro →Share this analysis with other traders
Disclaimer: The content on this page is for informational and educational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any security. Past performance does not guarantee future results. Consult a licensed financial advisor before making any investment decisions.
No sell-side coverage available for PDEX yet.
Common for small-cap names, ETFs, recent IPOs, and ADRs without US-listed sell-side coverage. When analysts publish, ratings appear here within one business day.
| Date | Open | Close | Δ | Vol |
|---|---|---|---|---|
| 05-15 | $57.73 | $59.27 | +2.67% | 0.0M |
| 05-18 | $59.01 | $59.16 | +0.25% | 0.1M |
| 05-19 | $58.99 | $60.78 | +3.03% | 0.0M |
| 05-20 | $60.50 | $63.47 | +4.91% | 0.0M |
| 05-21 | $63.45 | $62.61 | -1.32% | 0.1M |
Pro-Dex Inc designs, develops, manufactures, and sells powered surgical instruments for medical device original equipment manufacturers (OEMs) to various countries. Its product portfolio includes autoclavable, battery-powered, electric, and multi-function surgical drivers and shavers used mainly in orthopedic, thoracic, and craniomaxillofacial markets. The company also provides engineering, quality, regulatory consulting services, and manufactures rotary air motors utilized in various industries. Operating out of ISO-certified facilities in California, Pro-Dex serves hospitals, medical labs, and high-tech manufacturers, generating revenue through sales of surgical instruments and related services.
Indicator values from Polygon. Educational only — single- indicator triggers in isolation are not a complete trading signal.
Documents are served directly from sec.gov / the issuer's website — Stonvex does not proxy or store filings.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q1 2026 2026-03-31 | Q4 2025 2025-12-31 | Q3 2025 2025-09-30 | Annual 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $57.14M | $37.19M | $18.53M | $66.59M |
Operating Income | $9.46M | $6.37M | $3.11M | $10.69M |
Net Income | $10.80M | $6.87M | $4.68M | $8.98M |
EPS (Diluted) | $3.27 | $2.07 | $1.40 | $2.67 |
Total Assets | $74.98M | $62.26M | $64.30M | $61.19M |
Total Liabilities | $29.78M | $20.63M | $22.79M | $24.56M |
Cash & Equivalents | $6.63M | $5.27M | $33.00K | $33.00K |
Free Cash Flow OCF − CapEx | $7.24M | $5.71M | $2.21M | Not available |
Shares Outstanding | 3.20M | 3.21M | 3.26M | 3.26M |